Use of brom-ergocryptine in treating amenorrhea/galactorrhea

Arthur G. Shapiro

Research output: Contribution to journalArticlepeer-review

2 Scopus citations


Seven women with amenorrhea and galactorrhea, and no evidence of pituitary adenoma, were treated with brom-ergocryptine for two to 24 weeks. All seven patients had the resumption of regular menses within eight weeks, but six patients required 24 weeks of therapy to completely cease lactating. Two of the five women attempting to conceive became pregnant. Four of the five nonpregnant patients had a total recurrence of their symptoms after discontinuing the drug. Brom-ergocryptine appears to be very effective in inhibiting prolactin secretion and thus reestablishing normal ovulatory menstrual cycles and fertility.

Original languageEnglish (US)
Pages (from-to)720-721
Number of pages2
JournalSouthern medical journal
Issue number6
StatePublished - Jun 1977

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Use of brom-ergocryptine in treating amenorrhea/galactorrhea'. Together they form a unique fingerprint.

Cite this